Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision tag on the page updated to v3.7.0, replacing the previous v3.6.6. This indicates a minor update to the page's metadata or underlying CMS without changing the visible study content.
    Difference
    0.1%
    Check dated 2026-09-16T00:29:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label in the page footer updated from v3.6.5 to v3.6.6. This appears to be a site-version bump and does not alter the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-09-01T20:32:00.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update. No substantive study information or visible content changes occurred.
    Difference
    0.1%
    Check dated 2026-08-11T17:07:35.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor deployment update to the page. No study data or content changes are reflected in this update.
    Difference
    0.1%
    Check dated 2026-07-28T10:10:28.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    An update to the page revision from v3.6.2 to v3.6.3 was applied, signaling a new version of the page. This change records a version bump rather than a modification to the trial content.
    Difference
    0.1%
    Check dated 2026-07-07T02:40:11.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This indicates a platform or content update rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-06-29T17:44:59.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.